Man who defaulted on NS for 10 years returns to Singapore after business fails in Hong Kong, gets jail

SINGAPORE: A Singaporean by birth stayed in Hong Kong and defaulted on his National Service (NS) obligations for more than 10 years, but chose to return to Singapore for the sake of his family after his business was affected by the COVID-19 pandemic.

Vin Lau Jun Sheng, 29, knew that he might have to go to jail, but discussed the matter with his wife and decided the “best option” was to be Singapore citizens.

He was sentenced to six months’ jail on Friday (Apr 28), after pleading guilty to one charge under the Enlistment Act of failing to return to Singapore from August 2010 to October 2020, even though his exit permit had expired. A second charge was taken into consideration.

The court heard that Lau was born in Singapore to a man who was a Hong Kong citizen, and a woman who was Singaporean.

His parents divorced around 1997, when he was three years old. His father took him to live in Hong Kong, while his mother remained in Singapore.

Lau’s mother had told him about his NS obligations. But he didn’t bother to find out more as he wanted to continue living in Hong Kong with his father, the prosecutor said.

Around November 2009, Lau’s mother applied for an exit permit on behalf of her son, for overseas studies. An exit permit valid till July 2010 was issued to Lau.

Lau continued staying in Hong Kong even after his exit permit expired. He registered for NS in September 2010, and his mother applied to the Central Manpower Base for deferment, pending her son’s renunciation of Singapore citizenship.

But the application was incomplete as Lau’s mother did not submit certain required documents.

Authorities sent further letters telling Lau to report to the Central Manpower Base, but his mother told them he refused to return to Singapore. 

Around this time, in March 2011, Lau cut off contact with his mother. A police gazette and blacklist was raised against him.

RECONNECTS WITH MOTHER 

Lau reconnected with his mother on Facebook nine years later, around March 2020. He was now married, with a child, and operating an automobile repair shop in Hong Kong.

However, the shop closed down in August 2020 after business was affected by the pandemic. Lau told his mother that he intended to return to Singapore to settle down with his wife and child, and for them to obtain Singapore citizenship.

His mother contacted the Central Manpower Base to find out what procedures were required for her son to come home. She was told that her son had committed offences under the Enlistment Act, and was advised to give details of his return flight.

Lau returned to Singapore on Oct 3, 2020 and served a mandatory 14-day stay-home notice at a designated facility due to the pandemic.

He reported to the Central Manpower Base on Oct 20, 2020, and has since completed his NS.

Investigations revealed that Lau’s mother had told him of the need to serve NS when he returned, and that he had committed an offence for previously failing to do so.

Lau made an internet search and realised he could be liable to a jail term and a fine upon his return to Singapore.

But he discussed the matter with his wife and they decided that the best option was to be Singapore citizens. Lau said he was “prepared to face the consequences so that in future (he) can stay in Singapore and bring (his) family over to stay”.

He had remained outside Singapore without a valid exit permit for 10 years, one month and 10 days.

RETURN WAS “TACTICAL” MOVE: PROSECUTOR

The prosecution asked for six to eight months’ jail for Lau, noting that he had no previous convictions.

It was unlikely that an NS defaulter’s voluntary surrender was borne out of genuine remorse, said the prosecutor.

“Overseas defaulters who gamed the system and placed personal pursuits ahead of their NS obligations were likely to have planned to return eventually, after they have fulfilled their personal goals, such as after the completion of their studies or after a stint working abroad,” he said.

In other cases, an overseas defaulter may return to Singapore because his legal status in a foreign country is in jeopardy, or for family ties or professional reasons.

“In such cases, their voluntary surrender would be merely tactical, rather than arising from any genuine remorse.”

The prosecutor said Lau’s voluntary surrender was motivated by his personal interests, and asked for limited mitigating weight to be placed on his plea of guilt and voluntary surrender.

He cited a table from a High Court case, which laid out the starting point of a five to eight-month jail term for someone who had defaulted on NS for seven to 10 years.

The starting point goes up to 24 to 36 months’ jail for a person who defaults on NS for 17 to 23 or more years.

Lau is the 22nd defaulter to be sentenced to jail since the High Court set out the sentencing framework for NS defaulters in 2017.

In a previous statement, Singapore’s Defence Ministry (MINDEF) said it takes a firm stand against such offences.

“All male Singapore citizens and permanent residents (PRs) have a duty to serve NS and it is important that NS has the support and commitment of all Singaporeans,” said MINDEF.

“To achieve this, we have to adhere to the fundamental principles of universality and equity in NS. If we allow Singapore citizens or PRs who are overseas to evade NS or to choose when they want to serve NS, we are not being fair to the vast majority of our national servicemen who serve their country dutifully, and the institution of NS will be undermined.”

Continue Reading

High claim limits of Integrated Shield Plan riders may undermine efforts to reduce cancer costs: Experts

ENSURING GOOD OUTCOMES

While placing limits on IPs may prompt providers and patients to think twice about using unnecessary treatments and help to reduce spending, experts said it is important that treatment outcomes are not compromised.

“The increase in cancer drug spending through MediShield Life and the IPs will almost certainly be moderated through the Cancer Drug List (CDL) and the claim limits,” said Assoc Prof Lim.

“However, we have to ensure that this spend reduction is not accompanied by poorer outcomes and I hope the government is actively tracking cancer survival rates – for example, the quality of life – especially in lower income groups that may not have the means to afford riders.”

Oncologists who CNA spoke to said patients who do not have a rider would be most affected by the changes.

According to them, the maximum IP claim limit for cancer treatment – five times that of MediShield Life – is “too low” to cover the cost of most treatments in the private sector.

This is because the MediShield Life claim limit for cancer drug treatments is based on subsidised prices at public hospitals.

“The reimbursement rate is pegged at an unrealistically low level and the acquisition cost for drugs in the private sector remains as high as before,” said one private oncologist.

Speaking to CNA on the condition of anonymity, he said most of his patients who are currently taking non-CDL drugs have either advanced or incurable cancer.

“It’s not a matter of being kiasu (the fear of losing out). Many of them will run out of options eventually because their disease can’t be cured, which is why those with incurable and advanced diseases are often the ones who are using all these very expensive drugs that could not get on the CDL.”

He added: “We must also remember that advanced cancer patients cannot be treated and so there is no end date to their treatment. All we can do is to try to retain control of the cancer and extend their life as much as possible until the disease becomes resistant, gets worse and the patient dies.”

Mr Ong said that all insurers will maintain the current IP coverage of policyholders at least until Sep 30.

Beyond Sep 30, cancer patients whose treatments are not on the MOH list may still be covered by IP riders or other insurance plans they have. If not, they would have to shift to treatments that are on the list. 

Those who require drug treatments not on the list and are unable to pay can opt for subsidised care at public healthcare institutions, where they may apply for financial assistance.

For some private healthcare providers, matching their cancer drug prices to public hospitals is simply “not possible”, they said.

“We have no leverage with the pharmaceutical companies in the private sector because we are not united,” said another oncologist.

“Even a group practice with 10 doctors – which is already considered quite big – won’t be able to get it at the same price as public hospitals because there’s no bargaining power.”

WAIT AND SEE

With Singapore’s spending on cancer drugs projected to reach S$2.7 billion (US$2 billion) by the end of this decade, experts said the country has to rein in healthcare spending as the current trajectory is unsustainable.

However, they stressed that efforts need to be based on data and guided by patient outcomes.

“There is a ‘price to life’ and we need to know as citizens the price we are paying as we trade off managing costs with restricting access to medicines outside the Cancer Drug List,” said Assoc Prof Lim.

He added that a wait-and-see approach might be needed so that the government can see how the situation evolves and make policy adjustments as needed.

Assoc Prof Wee said IP riders remain relevant as it is important that such coverage options are available.

“This will allow those with the means to seek care in the private sector to do so and relieve the patient load in the public sector,” she said.

“My greater concern is one of equity. It will be most unfortunate if only a small proportion of the population can afford higher coverage.”

Continue Reading

Exploring the investible opportunity in life sciences & healthcare in the Asia Pacific region

It has been a tumultuous time for the life sciences and healthcare space in the Asia Pacific region over the last three years. A post-pandemic boom saw a rapid surge in private equity buyouts in the sector through 2020 and 2021, followed by a sharp correction through last year.

However, 2023 promises to be a year in which life sciences and healthcare regains its spot among the top priorities of investors, with several macroeconomic, demographic, and digital adoption trends buoying interest.

To gain deeper insights into what the future holds for this critical sector, FinanceAsia in partnership with DFIN created the Life Sciences & Healthcare Report 2023. Our report is based on a study of the most significant recent trends in the sector so far; as well as a glimpse into what the future holds via bespoke research involving key stakeholders.

We surveyed nearly 70 investors, legal and financial advisors who are actively engaged in the space, as well as professionals operating in life sciences and healthcare companies across the APAC region, to obtain informed insights on the opportunities and challenges that come with investments in the sector.

Here are some of the key takeaways:

  • The life sciences and healthcare sector is expected to bounce back in 2023: After a challenging 2022 in which factors like rising interest rates and a post pandemic rationalisation saw a decline in interest in the space, respondents across categories demonstrate optimism about the sector’s prospects.
  • An overwhelming 80% of investors expect to be involved in a transaction (funding, M&A, public listing): Over the next two years, a vast majority of investors surveyed believe they will engage with the life sciences and healthcare space. This is particularly significant since only 40% have engaged in transactions in the sectors over the last two years. Among investors who have not associated with the sector so far, 100% are ready to invest, given the right opportunity.
  • APAC will receive increased investor focus: The regions aging population, rising pressure on the public healthcare systems in some markets, as well as a sharp increase in health consumerism and digital innovations are among the major factors driving investor interest. While the life sciences and healthcare space has underperformed in the region compared to North America and Europe, innovative solutions in this space will be embraced by the region’s digital savvy middle class population which is growing in affluence.
  • Investors expect heightened M&A activity and more foreign investment: This is particularly true of mature markets. Most investors (56.3%) expect to see a growth in both volume and value of M&As over the next two years.

Read the report for a comprehensive overview of the life sciences and healthcare space including:

  1. The verticals most likely to attract investor interest and M&A.
  2. The impact of a recessive climate on investment.
  3. The biggest opportunities within the life sciences and healthcare according to investors, advisors, and professionals.
  4. The most critical challenges that the sector is dealing with.
  5. A forward-looking view on the scope and potential of life sciences and healthcare in the APAC region.

The report is essential reading for investors engaged in or thinking of engaging with the life sciences and healthcare, companies operating in the sector looking for growth opportunities, as well as advisors serving the space.
 

Download the full report now

 

¬ Haymarket Media Limited. All rights reserved.

Continue Reading

Singapore announces new property cooling measures, additional buyer’s stamp duty doubled to 60% for foreigners

8. For acquisitions made jointly by two or more parties of different profiles, the highest applicable ABSD rate will apply.

9. Married couples with at least one Singapore citizen spouse, who jointly purchase a second residential property, can continue to apply for a refund of ABSD, subject to conditions. These conditions include selling their first residential property within 6 months after (a) the date of purchase of the second residential property if this is a completed property, or (b) the issue date of the Temporary Occupation Permit (TOP) or Certificate of Statutory Completion (CSC) of the second residential property, whichever is earlier, if the second property is not completed at the time of purchase.

10. The ABSD currently does not affect those buying an HDB flat or executive condominium unit from housing developers with an upfront remission, if any of the joint acquirers/purchasers is a Singapore citizen. There will be no change to this policy.

11. The revised ABSD rates will apply to all residential properties acquired on or after Apr 27, 2023. There will be a transitional provision, where the ABSD rates on or before Apr 26, 2023 will apply for cases that meet all the conditions below:

a. The Option to Purchase (OTP) was granted by sellers to potential buyers on or before Apr 26, 2023;

b. This OTP is exercised on or before May 17, 2023, or within the OTP validity period, whichever is earlier; and

c. This OTP has not been varied on or after Apr 27, 2023.

12. Correspondingly, the Additional Conveyance Duties for Buyers (ACDB), which applies to qualifying acquisitions of equity interest in property holding entities (PHEs)6 will be raised from up to 46 per cent to up to 71 per cent.

Significant Increases in Housing Supply

13. The revisions to the ABSD rates to help moderate investment demand will complement our efforts to ramp up supply, to alleviate the tight housing market for both owner-occupation and rental.

14. We have increased the supply of private housing on the Confirmed List to 4,100 units for the 1H2023 Government Land Sales (GLS) programme, from 3,500 units for 2H2022. In 2022, we had injected a total of 6,300 units under the Confirmed List. For public housing, we have launched more than 23,000 flats in 2022 and will launch up to 23,000 flats in 2023. We are also prepared to launch up to 100,000 new flats in total between 2021 to 2025. We will continue to maintain a steady pipeline, to cater to growing housing demand. 

15. While COVID-19 had led to severe delays across private and public housing projects, we have made good progress to get back on track. With almost 40,000 public and private residential property completions in 2023, and near 100,000 units expected to be completed from 2023 to 2025, there will be significant housing supply coming onstream over the next few years.

16. The measures above have been calibrated to moderate housing demand while prioritising owner-occupation, and provide sufficient housing supply. The Government will continue to adjust our policies as necessary to ensure that they remain relevant, and promote a sustainable property market.

Continue Reading

Equinix and Astra form JV in Indonesia to develop digital infrastructure

The joint venture company will have a 75% and 25% equity steak
It will develop and operate the JK1 IBX in Jakarta’s Central Business District Equinix, a Nasdaq listed digital infrastructure company and Indonesian conglomerate, PT Astra International, announced a joint venture company on 11 April with 75% and 25% equity respectively to develop the…Continue Reading

US investment curbs on tech firms infuriate China

Beijing has called the Biden administration a “bully” as the White House is going to ban American funds and companies from investing in China’s high technology sectors. United States President Joe Biden is expected to sign an executive order that will restrict US companies and private equity and venture capital funds from investing in China’s […]Continue Reading

China stock rally highlights health of consumer rebound

China’s powerful stock rally has a remarkably important driver of momentum behind it: the nation’s 1.4 billion consumers. After a lackluster start, households are finally getting on board the post-Covid-19 reopening trade – and doing so en masse. In March alone, retail sales jumped 10.6% year on year. According to the National Bureau of Statistics, […]Continue Reading

The de-dollarization delusion

Is the dollar dying? In the wake of the Russia-Ukraine war and the massive growth in money supply and the US Federal Reserve’s assets in recent years, there has been a slew of stories and speeches extolling the virtue of de-dollarization.  The most recent came last week, when Brazilian President Luiz Inácio Lula da Silva called for the establishment […]Continue Reading

EU to sanction home appliance exports to Russia

Since the start of the Russo-Ukrainian conflict in February 2022, the European Union has ratified 10 sanctions packages designed to undermine Russia’s capacity to wage war in Ukraine. Now, kitchen appliances are in the EU’s crosshairs.  British newspaper The Telegraph, claiming to have seen a confidential EU report, says Brussels is considering imposing trade restrictions “on […]Continue Reading